|
|
|
| home > white papers > Soothing the Logistical Headache of Clinical Trials - Equilibrium Travel Management |
|
|
 WHITE PAPERS |
|
Equilibrium Travel Management
|
|
Soothing the Logistical Headache of Clinical Trials
|
|
As many as 30 per cent of subjects on phase three clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial. It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
|
|
|
|
|
|
|
 |
White Papers |
 |
|
The Importance of ADCC in Assessing Clinically Relevant Differences
Sartorius Stedim BioOutsource Ltd
Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >> |
|
 |
Industry Events |
 |
Pre-Filled Syringes & Injectable Drug Devices Europe
16-17 January 2019, Copthorne Tara Hotel, London
SMi is proud to present their 11th annual European conference and
exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes &
Injectable Drug Devices Europe. The event will take place on the 16th-17th of
January 2019, in London.
More info >> |
|
|
|
